The Valley Desk

LetterHaemophilia : the official journal of the World Federation of HemophiliaPublished

Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Letter
Venue
Haemophilia : the official journal of the World Federation of Hemophilia
Published
Subject terms
Gene therapy; Haemophilia B; Joint Health; Haemophilia Joint Health Score (Hjhs); Fidanacogene Elaparvovec; Annualised Bleeding Rate (Abr)
PubMed ID
41263376
Added to directory
Source checked

Report a correction or request removal